Skip to content

International Union of Quaternary Research (INQUA), INQUA – Commission on Stratigraphy and Chronology (SACCOM)

Scientific Abstracts, qPCR, PCR, RT-PCR, cDNA, RNA

Menu
  • Home
  • Isotype
  • peptide
  • Lenti
  • elisa kits
  • antibody
  • Distributors
  • vector
  • cDNA
  • Contact Us
Menu

MERISCREEN COVID-19 ANTIGEN TEST KIT

Posted on May 5, 2021May 5, 2021 by Leah

The MeriScreen COVID-19 Antigen Detection Test is a rapid immunochromatographic assay test for the qualitative detection of SARS-CoV-2 antigen in a nasopharyngeal swab specimen from a human body.

Indication

  • Ideal for early detection of COVID – 19
  • Detects COVID-19 from the onset of symptoms
  • Suitable for field tests

Founded in 2006, Meril is an India-based global medical device company that is dedicated to the innovation, design and development of cutting-edge, clinically relevant and next-generation devices. Our fundamental objective is to advocate for the alleviation of human suffering and to improve the quality of life. To enable this, we are committed to R&D, innovation in medical technology manufacturing, scientific communication, and contemporary distribution avenues.

Merril was born with the aim of improving the quality of human life through innovative and advanced healthcare solutions. As a manufacturer of medical devices, we exist to enhance inventiveness in health care so that people’s lives are enriched. We continually seek excellence to provide answers to some of the toughest questions in medicine.

Merril manufactures medical solutions in the form of vascular intervention devices, orthopedic supplements, in vitro diagnostic products, endosurgery and otolaryngology. Our main commitment is to ensure the delivery of advanced healthcare solutions. Our inclination towards research and development is reflected in our various offerings. We ensure that we comply with the best quality standards in manufacturing, scientific communication and distribution to offer pioneering health products in the world.

We collaborate with global physicians and innovators to identify unmet clinical needs and develop revolutionary therapies. We encourage research and academic collaborations and remain available to interact on exciting opportunities.

Headquartered in India and with a workforce of over 4,000, Meril currently conducts business in over 100 countries. We have 100% subsidiaries in India, the United States, Germany, Brazil, Russia, South Africa, Bangladesh and Turkey. We have also established operations in China and Japan.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Compare rec. lab reagents for research
  • Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
  • Engineering hybrid genes without the use of restriction enzymes: gene splicing
  • Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
  • Supervised risk predictor of breast cancer based on intrinsic subtypes.

Recent Comments

    Categories

    • antibody
    • cDNA
    • elisa kits
    • Isotype
    • Lenti
    • pcr
    • peptide
    • rna
    • Uncategorized
    • vector
    December 2023
    M T W T F S S
     123
    45678910
    11121314151617
    18192021222324
    25262728293031
    « Dec    

    Categories

    • antibody
    • cDNA
    • elisa kits
    • Isotype
    • Lenti
    • pcr
    • peptide
    • rna
    • Uncategorized
    • vector

    Recent Posts

    • Compare rec. lab reagents for research
    • Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
    • Engineering hybrid genes without the use of restriction enzymes: gene splicing
    • Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
    • Supervised risk predictor of breast cancer based on intrinsic subtypes.
    © 2023 International Union of Quaternary Research (INQUA), INQUA – Commission on Stratigraphy and Chronology (SACCOM) | Powered by Superbs Personal Blog theme